Robert S Ohgami

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint E-Cadherin Is a Specific Marker for Erythroid Differentiation and Has Utility, in Combination With CD117 and CD34, for Enumerating Myeloblasts in Hematopoietic Neoplasms
    Robert S Ohgami
    Dept of Pathology, Stanford University Medical Center, 300 Pasteur Dr, Rm L235, Stanford, CA 94305
    Am J Clin Pathol 141:656-64. 2014
  2. doi request reprint TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma
    Robert S Ohgami
    Department of Pathology, Stanford University, CA 94305, USA
    Am J Surg Pathol 36:1619-28. 2012
  3. doi request reprint Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma
    Robert S Ohgami
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Adv Anat Pathol 20:137-40. 2013
  4. doi request reprint DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups
    Robert S Ohgami
    Department of Pathology, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA
    Br J Haematol 159:182-90. 2012
  5. doi request reprint The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow
    Sheren F Younes
    Dept of Pathology, Division of Oncology, Stanford University School of Medicine, CA 94305, USA
    Am J Clin Pathol 135:697-708. 2011

Collaborators

Detail Information

Publications5

  1. doi request reprint E-Cadherin Is a Specific Marker for Erythroid Differentiation and Has Utility, in Combination With CD117 and CD34, for Enumerating Myeloblasts in Hematopoietic Neoplasms
    Robert S Ohgami
    Dept of Pathology, Stanford University Medical Center, 300 Pasteur Dr, Rm L235, Stanford, CA 94305
    Am J Clin Pathol 141:656-64. 2014
    ..Conclusions In marrow specimens, E-cadherin is a useful marker for erythroid differentation. ..
  2. doi request reprint TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma
    Robert S Ohgami
    Department of Pathology, Stanford University, CA 94305, USA
    Am J Surg Pathol 36:1619-28. 2012
    ..Our studies not only present several detailed cases of indolent T-lymphoblastic proliferations, but also correlate these populations with specific hematologic diseases...
  3. doi request reprint Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma
    Robert S Ohgami
    Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
    Adv Anat Pathol 20:137-40. 2013
    ....
  4. doi request reprint DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups
    Robert S Ohgami
    Department of Pathology, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA
    Br J Haematol 159:182-90. 2012
    ....
  5. doi request reprint The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow
    Sheren F Younes
    Dept of Pathology, Division of Oncology, Stanford University School of Medicine, CA 94305, USA
    Am J Clin Pathol 135:697-708. 2011
    ..In the bone marrow, staining for HGAL or CD10 can be helpful in making a diagnosis of FL, although they are absent in a subset of cases...